ADMA Biologics reported FY 2024 revenue of $426.5 million, achieving significant increases in net income and adjusted EBITDA. ADMA Biologics, Inc. reported strong financial results for FY 2024, ...
The Progressive Corporation announced strong financial results for November 2024, reporting net premiums written of $5.56 billion, a significant 18% increase compared to $4.73 billion in November 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback